EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

A scoping review of alopecia areata and its relationship to COVID-19 vaccinations

Hailey Konisky, Solbie Choi, Aditi Valada, Tyler M Andriano, Kseniya Kobets

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03583-z ↗

Kurz gefasst

Scoping Review in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Hailey Konisky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. hailey.konisky@einsteinmed.edu. Hauptthemen laut MEDLINE: Alopecia Areata, COVID-19 Vaccines, COVID-19. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In response to the COVID-19 pandemic several vaccines were produced, including novel mRNA and viral vector-based vaccines. Though COVID-19 had its own associated dermatological sequelae, the vaccines were associated with a new set of cutaneous side effects, including hypersensitivity reactions, vasculitis, and autoimmune-mediated reactions. Notably, alopecia areata (AA) was reported in several patients closely following a COVID-19 vaccine, especially in those with a personal or family history of AA. A PubMed and Google Scholar search was conducted in July 2024 which resulted in 26 case reports/case series, 1 prospective study, and 3 cross-sectional retrospective chart reviews. Based on our holistic literature review, there is no evidence to support an increased association between COVID-19 vaccination and AA. Despite recent literature highlighting the incidence of de novo and recurrent AA after COVID-19 vaccines, several large retrospective analyses have shown that the overall incidence of AA in vaccinated individuals does not differ from that of historical controls. The potential for de novo AA after COVID-19 vaccine is low and the benefit of being vaccinated far outweighed the risks, especially within the first few years of COVID-19 vaccine rollout. While the decision to get vaccinated is a personal choice, the threat of developing AA secondary to vaccination should not be a deterrent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataCOVID-19 VaccinesCOVID-19HumansSARS-CoV-2VaccinationIncidence

Stichwörter der Autor:innen

Alopecia areataAlopecia totalisAlopecia universalisCOVID-19 vaccineHair lossSARS-CoV-2 vaccineVaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Albert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY, 10461, USA. hailey.konisky@einsteinmed.edu.
  • Albert Einstein College of Medicine, Montefiore Medical Center, 1300 Morris Park Avenue, Bronx, NY, 10461, USA.

Zitieren

APA

Konisky, H., Choi, S., Valada, A., Andriano, T. M., & Kobets, K. (2024). A scoping review of alopecia areata and its relationship to COVID-19 vaccinations. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03583-z

Vancouver

Konisky H, Choi S, Valada A, Andriano TM, Kobets K. A scoping review of alopecia areata and its relationship to COVID-19 vaccinations. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03583-z

BibTeX
@article{Konisky2024,
  author = {Konisky, Hailey and Choi, Solbie and Valada, Aditi and Andriano, Tyler M and Kobets, Kseniya},
  title = {A scoping review of alopecia areata and its relationship to COVID-19 vaccinations},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03583-z}
}
Kostenlos starten →